APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prostaglandin I2

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prostaglandin I2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174029350321 December 2025189 pages

Choose your research edition.

Industry ResearchProstaglandin I2 Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostaglandin I2 Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Prostaglandin I2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostaglandin I2 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostaglandin I2 Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Prostaglandin I2 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Prostaglandin I2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prostaglandin I2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostaglandin I2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prostaglandin I2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prostaglandin I2 include Teva, J & J, GSK, Bayer AG, United Therapeutics, Toray and Tide Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prostaglandin I2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostaglandin I2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostaglandin I2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prostaglandin I2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Prostaglandin I2 Segment by Company

Teva

J & J

GSK

Bayer AG

United Therapeutics

Toray

Tide Pharma

Prostaglandin I2 Segment by Type

Epoprostenol Sodium

Iloprost

Treprostinil

Beraprost Sodium

Prostaglandin I2 Segment by Application

For Oral

For Inhalation

For Injection

Prostaglandin I2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin I2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin I2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin I2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prostaglandin I2 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostaglandin I2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prostaglandin I2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prostaglandin I2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prostaglandin I2 Industry Trends Table 2. Prostaglandin I2 Industry Drivers Table 3. Prostaglandin I2 Industry Opportunities and Challenges Table 4. Prostaglandin I2 Industry Restraints Table 5. Global Prostaglandin I2 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prostaglandin I2 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prostaglandin I2 Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Prostaglandin I2 Sales Market Share by Manufacturers Table 9. Global Prostaglandin I2 Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Prostaglandin I2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prostaglandin I2 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prostaglandin I2 Manufacturers, Product Type & Application Table 13. Global Prostaglandin I2 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prostaglandin I2 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Epoprostenol Sodium Table 17. Major Manufacturers of Iloprost Table 18. Major Manufacturers of Treprostinil Table 19. Major Manufacturers of Beraprost Sodium Table 20. Global Prostaglandin I2 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 22. Global Prostaglandin I2 Sales by Type (2027-2032) & (k units) Table 23. Global Prostaglandin I2 Sales Market Share by Type (2021-2026) Table 24. Global Prostaglandin I2 Sales Market Share by Type (2027-2032) Table 25. Global Prostaglandin I2 Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Prostaglandin I2 Revenue by Type (2021-2026) & (k units) Table 27. Global Prostaglandin I2 Revenue by Type (2027-2032) & (k units) Table 28. Global Prostaglandin I2 Revenue Market Share by Type (2021-2026) Table 29. Global Prostaglandin I2 Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of For Oral Table 31. Major Manufacturers of For Inhalation Table 32. Major Manufacturers of For Injection Table 33. Global Prostaglandin I2 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 35. Global Prostaglandin I2 Sales by Application (2027-2032) & (k units) Table 36. Global Prostaglandin I2 Sales Market Share by Application (2021-2026) Table 37. Global Prostaglandin I2 Sales Market Share by Application (2027-2032) Table 38. Global Prostaglandin I2 Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Prostaglandin I2 Revenue by Application (2021-2026) & (k units) Table 40. Global Prostaglandin I2 Revenue by Application (2027-2032) & (k units) Table 41. Global Prostaglandin I2 Revenue Market Share by Application (2021-2026) Table 42. Global Prostaglandin I2 Revenue Market Share by Application (2027-2032) Table 43. Global Prostaglandin I2 Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Prostaglandin I2 Sales by Region (2021-2026) & (k units) Table 45. Global Prostaglandin I2 Sales Market Share by Region (2021-2026) Table 46. Global Prostaglandin I2 Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Prostaglandin I2 Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Prostaglandin I2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 50. North America Prostaglandin I2 Sales by Country (2027-2032) & (k units) Table 51. Europe Prostaglandin I2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 53. Europe Prostaglandin I2 Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Prostaglandin I2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Prostaglandin I2 Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Prostaglandin I2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Prostaglandin I2 Sales by Country (2027-2032) & (k units) Table 60. Global Prostaglandin I2 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Prostaglandin I2 Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Prostaglandin I2 Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Prostaglandin I2 Revenue Market Share by Region (2021-2026) Table 64. Global Prostaglandin I2 Revenue Market Share by Region (2027-2032) Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva Prostaglandin I2 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Prostaglandin I2 Product Portfolio Table 69. Teva Recent Development Table 70. J & J Company Information Table 71. J & J Business Overview Table 72. J & J Prostaglandin I2 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. J & J Prostaglandin I2 Product Portfolio Table 74. J & J Recent Development Table 75. GSK Company Information Table 76. GSK Business Overview Table 77. GSK Prostaglandin I2 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. GSK Prostaglandin I2 Product Portfolio Table 79. GSK Recent Development Table 80. Bayer AG Company Information Table 81. Bayer AG Business Overview Table 82. Bayer AG Prostaglandin I2 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Bayer AG Prostaglandin I2 Product Portfolio Table 84. Bayer AG Recent Development Table 85. United Therapeutics Company Information Table 86. United Therapeutics Business Overview Table 87. United Therapeutics Prostaglandin I2 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. United Therapeutics Prostaglandin I2 Product Portfolio Table 89. United Therapeutics Recent Development Table 90. Toray Company Information Table 91. Toray Business Overview Table 92. Toray Prostaglandin I2 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Toray Prostaglandin I2 Product Portfolio Table 94. Toray Recent Development Table 95. Tide Pharma Company Information Table 96. Tide Pharma Business Overview Table 97. Tide Pharma Prostaglandin I2 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Tide Pharma Prostaglandin I2 Product Portfolio Table 99. Tide Pharma Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Prostaglandin I2 Distributors List Table 103. Prostaglandin I2 Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Prostaglandin I2 Product Image Figure 2. Global Prostaglandin I2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostaglandin I2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostaglandin I2 Sales (2021-2032) & (k units) Figure 5. Global Prostaglandin I2 Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Prostaglandin I2 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Epoprostenol Sodium Image Figure 9. Iloprost Image Figure 10. Treprostinil Image Figure 11. Beraprost Sodium Image Figure 12. Global Prostaglandin I2 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Prostaglandin I2 Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Prostaglandin I2 Sales Market Share by Type (2021-2032) Figure 15. Global Prostaglandin I2 Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Prostaglandin I2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Prostaglandin I2 Revenue Market Share by Type (2021-2032) Figure 18. For Oral Image Figure 19. For Inhalation Image Figure 20. For Injection Image Figure 21. Global Prostaglandin I2 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Prostaglandin I2 Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Prostaglandin I2 Sales Market Share by Application (2021-2032) Figure 24. Global Prostaglandin I2 Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Prostaglandin I2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Prostaglandin I2 Revenue Market Share by Application (2021-2032) Figure 27. North America Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Prostaglandin I2 Sales Market Share by Country (2021-2032) Figure 29. U.S. Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Prostaglandin I2 Sales Market Share by Country (2021-2032) Figure 34. Germany Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Prostaglandin I2 Sales Market Share by Country (2021-2032) Figure 41. China Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Prostaglandin I2 Sales Market Share by Country (2021-2032) Figure 49. Brazil Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Prostaglandin I2 Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Prostaglandin I2 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Prostaglandin I2 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Figure 60. North America Prostaglandin I2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Figure 62. Europe Prostaglandin I2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Prostaglandin I2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Prostaglandin I2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Prostaglandin I2 Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Prostaglandin I2 Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Epoprostenol Sodium
  • Iloprost
  • Treprostinil
  • Beraprost Sodium
Applications
  • For Oral
  • For Inhalation
  • For Injection
Companies covered
  • Teva
  • J & J
  • GSK
  • Bayer AG
  • United Therapeutics
  • Toray
  • Tide Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prostaglandin I2 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prostaglandin I2 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prostaglandin I2 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prostaglandin I2 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prostaglandin I2 Market Dynamics
  1. 2.1 Prostaglandin I2 Industry Trends
  2. 2.2 Prostaglandin I2 Industry Drivers
  3. 2.3 Prostaglandin I2 Industry Opportunities and Challenges
  4. 2.4 Prostaglandin I2 Industry Restraints
3 Prostaglandin I2 Market by Manufacturers
  1. 3.1 Global Prostaglandin I2 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prostaglandin I2 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prostaglandin I2 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prostaglandin I2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostaglandin I2 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prostaglandin I2 Manufacturers, Product Type & Application
  7. 3.7 Global Prostaglandin I2 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostaglandin I2 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostaglandin I2 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostaglandin I2 Tier 1, Tier 2, and Tier 3
4 Prostaglandin I2 Market by Type
  1. 4.1 Prostaglandin I2 Type Introduction
  2. 4.1.1 Epoprostenol Sodium
  3. 4.1.2 Iloprost
  4. 4.1.3 Treprostinil
  5. 4.1.4 Beraprost Sodium
  6. 4.2 Global Prostaglandin I2 Sales by Type
  7. 4.2.1 Global Prostaglandin I2 Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Prostaglandin I2 Sales by Type (2021-2032)
  9. 4.2.3 Global Prostaglandin I2 Sales Market Share by Type (2021-2032)
  10. 4.3 Global Prostaglandin I2 Revenue by Type
  11. 4.3.1 Global Prostaglandin I2 Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Prostaglandin I2 Revenue by Type (2021-2032)
  13. 4.3.3 Global Prostaglandin I2 Revenue Market Share by Type (2021-2032)
5 Prostaglandin I2 Market by Application
  1. 5.1 Prostaglandin I2 Application Introduction
  2. 5.1.1 For Oral
  3. 5.1.2 For Inhalation
  4. 5.1.3 For Injection
  5. 5.2 Global Prostaglandin I2 Sales by Application
  6. 5.2.1 Global Prostaglandin I2 Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prostaglandin I2 Sales by Application (2021-2032)
  8. 5.2.3 Global Prostaglandin I2 Sales Market Share by Application (2021-2032)
  9. 5.3 Global Prostaglandin I2 Revenue by Application
  10. 5.3.1 Global Prostaglandin I2 Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Prostaglandin I2 Revenue by Application (2021-2032)
  12. 5.3.3 Global Prostaglandin I2 Revenue Market Share by Application (2021-2032)
6 Global Prostaglandin I2 Sales by Region
  1. 6.1 Global Prostaglandin I2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prostaglandin I2 Sales by Region (2021-2032)
  3. 6.2.1 Global Prostaglandin I2 Sales by Region (2021-2026)
  4. 6.2.2 Global Prostaglandin I2 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prostaglandin I2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prostaglandin I2 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prostaglandin I2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prostaglandin I2 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prostaglandin I2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prostaglandin I2 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prostaglandin I2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prostaglandin I2 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prostaglandin I2 Revenue by Region
  1. 7.1 Global Prostaglandin I2 Revenue by Region
  2. 7.1.1 Global Prostaglandin I2 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prostaglandin I2 Revenue by Region (2021-2026)
  4. 7.1.3 Global Prostaglandin I2 Revenue by Region (2027-2032)
  5. 7.1.4 Global Prostaglandin I2 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prostaglandin I2 Revenue (2021-2032)
  8. 7.2.2 North America Prostaglandin I2 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prostaglandin I2 Revenue (2021-2032)
  11. 7.3.2 Europe Prostaglandin I2 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prostaglandin I2 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prostaglandin I2 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prostaglandin I2 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prostaglandin I2 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Prostaglandin I2 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Prostaglandin I2 Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 J & J
  8. 8.2.1 J & J Company Information
  9. 8.2.2 J & J Business Overview
  10. 8.2.3 J & J Prostaglandin I2 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 J & J Prostaglandin I2 Product Portfolio
  12. 8.2.5 J & J Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Prostaglandin I2 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK Prostaglandin I2 Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Bayer AG
  20. 8.4.1 Bayer AG Company Information
  21. 8.4.2 Bayer AG Business Overview
  22. 8.4.3 Bayer AG Prostaglandin I2 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer AG Prostaglandin I2 Product Portfolio
  24. 8.4.5 Bayer AG Recent Developments
  25. 8.5 United Therapeutics
  26. 8.5.1 United Therapeutics Company Information
  27. 8.5.2 United Therapeutics Business Overview
  28. 8.5.3 United Therapeutics Prostaglandin I2 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 United Therapeutics Prostaglandin I2 Product Portfolio
  30. 8.5.5 United Therapeutics Recent Developments
  31. 8.6 Toray
  32. 8.6.1 Toray Company Information
  33. 8.6.2 Toray Business Overview
  34. 8.6.3 Toray Prostaglandin I2 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Toray Prostaglandin I2 Product Portfolio
  36. 8.6.5 Toray Recent Developments
  37. 8.7 Tide Pharma
  38. 8.7.1 Tide Pharma Company Information
  39. 8.7.2 Tide Pharma Business Overview
  40. 8.7.3 Tide Pharma Prostaglandin I2 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Tide Pharma Prostaglandin I2 Product Portfolio
  42. 8.7.5 Tide Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prostaglandin I2 Value Chain Analysis
  2. 9.1.1 Prostaglandin I2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prostaglandin I2 Production Mode & Process
  6. 9.2 Prostaglandin I2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prostaglandin I2 Distributors
  9. 9.2.3 Prostaglandin I2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst